Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)

NCT01893372 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Eltrombopag
DRUG: Hypomethylating Agent (HMA)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]